PYC THERAPEUTICS LIMITED — Major Shareholding Notification 2012

Aug 20, 2012

		FOLIN DUS Corporations Act 2001 Section 671B
	Notice of initial substantial holder
To Company Name/Scheme	PHYLOGICA LIMITED
ACN/ARSN	R8 391 961 O
1. Details of substantial holder (1) Name ACN/ARSN (if applicable)
The holder became a substantial holder on	618112
2. Details of voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:
Class of securities (4)	Number of securities		Person's votes (5)
FPO	D. 6.462, 263	26.482,263		6.53%
The nature of the relevant interest the substantial holder organ associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: Holder of relevant interest		Nature of relevant interest (7) KBHOCKINGS PRIVATESFZACHOWER TOCONTROL VOTING		Class and number of securities FPO
	ANDOR DISPOSAL OF SECURITIES		26,462,26
4. Datails of present registered holders The persons registered as holders of the securities referred to in paragraph 3 above are as follows:
Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)		Class and number of securities
BEF+DC HOCKINGS KBEACKINGS PRIVATE SF 2 ACD B AOCKINGS 26,462,263				ffo
5. Consideration The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:
Holder of relevant	tate of acquisition	Consideration (9)	Non-cash	Class and number of securities
interest		Cash
KB HOCKINGS PRIVATE		S 54.000		2,000,000 FPO 3,000,000 FPO

$\mathcal{L}_{\mathcal{A}}$

$\bar{z}$

Name and ACN/ARSN (If applicable) Nature of association Addresses The addresses of persons named in this form are as follows: Name Address BEF HOCKINGS CLO SUITE 20, HOLLYWOOD MEDICAL CENTRE 59 Signature BERNARD HOCKINGS print name Capacity sign here $18'$ $6'$ $12$ date ውኒ DIRECTIONS (# If there are a number of substantial holders with similar or related relaxant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an anneatine to the form if the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is dearly set out in paragraph 7 of the Ø See the definition of "associate" in section 9 of the Corporations Act 2001. $\omega$ See the definition of "relevant interest" in sections 600 and 6718(7) of the Corporations Act 2001. $\left( 9 \right)$ The voting shares of a company constitute one class unless divided into separate classes. Θ. The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant 0 The person's votes divided by the total votes in the body corporate or scheme multiplied by 100. Ø Include details of: (а) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 6718(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or atrangement, must accompany this form, together with a written statement vertifying this contract, scheme or arrangement, and (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies). See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest anises because of an option) write "unknown". Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.	The reasons the persons named in paragraph 3 above are aspociates of the substantial holder are as follows: